Premium
Single probiotic supplement suppresses colitis‐associated colorectal tumorigenesis by modulating inflammatory development and microbial homeostasis
Author(s) -
Rong Jingjing,
Liu Shuzhan,
Hu Chao,
Liu Chen
Publication year - 2019
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/jgh.14516
Subject(s) - azoxymethane , dysbiosis , medicine , colitis , inflammation , cancer research , carcinogenesis , downregulation and upregulation , bacteroides , colorectal cancer , immunology , cancer , gut flora , microbiology and biotechnology , biology , bacteria , biochemistry , genetics , gene
Background and Aim Chronic inflammation is a major contributor to the initiation and progression of cancers. Lactobacillus helveticus NS8, which was originally separated from fermented koumiss, exhibited anti‐inflammatory functions in our prior studies. In this study, NS8 was investigated for its potential to prevent colitis‐associated colorectal cancer (CAC). Methods The protective effects of NS8 against CAC was explored by employing the azoxymethane plus dextran sodium sulfate‐induced carcinogenesis mouse model. The prevalences of T cells expressing specific inflammatory cytokines were measured by flow cytometry at the early stage of CAC. Inflammatory modulation by NS8 was also tested in the Caco2‐Raw264.7 cell co‐culture system. The alternations in the intestinal microbiota following the health–inflammation–cancer sequence were analyzed by 16S rDNA sequencing. Results Oral intake of NS8 lactobacilli clearly reduced tumor number and the degree of hyperplasia. The increased proliferation of enterocytes at the early stage of CAC was significantly suppressed by NS8, while the level of apoptosis was elevated. The anticancer effects of NS8 were associated with its anti‐colitis outcomes before tumor formation. NS8 significantly suppressed the activation of NF‐κB and upregulated the anti‐inflammatory cytokine IL‐10. Further analysis revealed the marked downregulation of IL‐17‐producing T cells by NS8. Furthermore, NS8 modulated intestinal dysbiosis by promoting beneficial commensal microbes while suppressing cancer‐associated microbes. Notably, Bacteroides acidifaciens was the most sensitive commensal bacteria to NS8 intervention. Conclusion These results provide insight into the protective effects of L. helveticus NS8 against colorectal cancer.